|Articles|April 14, 2023
Pharma USA 2023: Digital Therapeutics and Pharma
Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.
Advertisement
Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
2
argenx Acquires Forte Biosciences for $2.2 Billion
3
Where the True Bottlenecks Exist at FDA for Clinical Trials
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5